Histopathologic features predict survival in diffuse pleural malignant mesothelioma on pleural biopsies

[1]  K. Geisinger,et al.  A Histomorphologic Grading System That Predicts Overall Survival in Diffuse Malignant Peritoneal Mesothelioma With Epithelioid Subtype , 2016, The American journal of surgical pathology.

[2]  K. Nackaerts,et al.  Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial. , 2015, The Lancet. Oncology.

[3]  G. Karpathiou,et al.  Pleural neoplastic pathology. , 2015, Respiratory medicine.

[4]  E. Taioli,et al.  Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma. , 2015, The Annals of thoracic surgery.

[5]  J. Pairon,et al.  [The French mesothelioma network from 1998 to 2013]. , 2014, Annales de pathologie.

[6]  M. Papotti,et al.  Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma , 2014, Modern Pathology.

[7]  A. Gown,et al.  Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. , 2013, Archives of pathology & laboratory medicine.

[8]  Prasad S Adusumilli,et al.  A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma , 2012, Modern Pathology.

[9]  C. Sima,et al.  A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma , 2012, Modern Pathology.

[10]  R. Ramlau,et al.  Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  E. Brun,et al.  Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma. , 2006, Archives of pathology & laboratory medicine.

[12]  Daniele Zink,et al.  Nuclear structure in cancer cells , 2004, Nature Reviews Cancer.

[13]  Bignold Lp Pathogenetic mechanisms of nuclear pleomorphism of tumour cells based on the mutator phenotype theory of carcinogenesis. , 2003, Histology and histopathology.

[14]  D. Gisselsson Tumour morphology--interplay between chromosome aberrations and founder cell differentiation. , 2002, Histology and histopathology.

[15]  L. Thompson Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to Separate Benign From Malignant Neoplasms: A Clinicopathologic and Immunophenotypic Study of 100 Cases , 2002, The American journal of surgical pathology.

[16]  B. Scheithauer,et al.  Meningioma grading: an analysis of histologic parameters. , 1997, The American journal of surgical pathology.

[17]  W D Dupont,et al.  Histologic grading of breast carcinoma. A reproducibility study , 1994, Cancer.

[18]  E. van Marck,et al.  Proliferation in malignant mesothelioma as determined by mitosis counts and immunoreactivity for proliferating cell nuclear antigen (PCNA) , 1994, The Journal of pathology.

[19]  S. Fuhrman,et al.  Prognostic significance of morphologic parameters in renal cell carcinoma , 1982, The American journal of surgical pathology.

[20]  Jonathan I. Epstein,et al.  WHO Classification of of Tumours of the Urinary System and Male Genital Organs , 2016 .

[21]  Beata Kalatova,et al.  Tripolar mitosis in human cells and embryos: occurrence, pathophysiology and medical implications. , 2015, Acta histochemica.

[22]  F. Demirağ,et al.  Prognostic factors in malignant pleural mesothelioma: a retrospective study of 60 Turkish patients. , 2015, Journal of cancer research and therapeutics.

[23]  W. Travis WHO classification of tumours of the lung, pleura, thymus and heart , 2015 .

[24]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.